These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11444762)

  • 1. Methodology to measure onset of action.
    Thase ME
    J Clin Psychiatry; 2001; 62 Suppl 15():18-21. PubMed ID: 11444762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring onset of antidepressant action in clinical trials: an overview of definitions and methodology.
    Leon AC
    J Clin Psychiatry; 2001; 62 Suppl 4():12-6; discussion 37-40. PubMed ID: 11229782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ideal trial to test differential onset of antidepressant effect.
    Leon AC; Blier P; Culpepper L; Gorman JM; Hirschfeld RM; Nierenberg AA; Roose SP; Rosenbaum JF; Stahl SM; Trivedi MH
    J Clin Psychiatry; 2001; 62 Suppl 4():34-6; discussion 37-40. PubMed ID: 11229787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI; McFall JP
    J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors contributing to failed trials of new agents: can technology prevent some problems?
    Greist JH; Mundt JC; Kobak K
    J Clin Psychiatry; 2002; 63 Suppl 2():8-13. PubMed ID: 15453008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are two antidepressant mechanisms better than one? Issues in clinical trial design and analysis.
    Leon AC
    J Clin Psychiatry; 2004; 65 Suppl 4():31-6. PubMed ID: 15046539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are 2-week trials sufficient to indicate efficacy?
    Montgomery SA
    Psychopharmacol Bull; 1995; 31(1):41-4. PubMed ID: 7675988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of exclusion criteria in antidepressant clinical trials: a replication study.
    Zetin M; Hoepner CT
    J Clin Psychopharmacol; 2007 Jun; 27(3):295-301. PubMed ID: 17502778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants: can we determine how quickly they work? Issues from the literature.
    Derivan AT
    Psychopharmacol Bull; 1995; 31(1):23-8. PubMed ID: 7675984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECT and onset of action.
    Roose SP; Nobler M
    J Clin Psychiatry; 2001; 62 Suppl 4():24-6; discussion 37-40. PubMed ID: 11229784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating antidepressant therapies: remission as the optimal outcome.
    Thase ME
    J Clin Psychiatry; 2003; 64 Suppl 13():18-25. PubMed ID: 14552652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction: early onset of antidepressant action.
    Rosenbaum JF
    J Clin Psychiatry; 2001; 62 Suppl 4():3. PubMed ID: 11229786
    [No Abstract]   [Full Text] [Related]  

  • 16. Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz.
    Rickels K; Robinson DS
    J Clin Psychopharmacol; 2009 Apr; 29(2):197-8; author reply 198-9. PubMed ID: 19512995
    [No Abstract]   [Full Text] [Related]  

  • 17. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
    Laenen A; Alonso A; Molenberghs G; Vangeneugden T; Mallinckrodt CH
    J Psychiatr Res; 2009 Apr; 43(7):730-8. PubMed ID: 18986657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for producing faster acting antidepressants.
    Adell A; Castro E; Celada P; Bortolozzi A; Pazos A; Artigas F
    Drug Discov Today; 2005 Apr; 10(8):578-85. PubMed ID: 15837601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting methodologies for the evaluation of differences in time to response between antidepressants.
    Montgomery SA; Bech P; Blier P; Möller HJ; Nierenberg AA; Pinder RM; Quitkin FM; Reimitz PE; Rosenbaum JF; Rush AJ; Stassen HH; Thase ME
    J Clin Psychiatry; 2002 Aug; 63(8):694-9. PubMed ID: 12197449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
    Zimmerman M; Mattia JI; Posternak MA
    Am J Psychiatry; 2002 Mar; 159(3):469-73. PubMed ID: 11870014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.